120 related articles for article (PubMed ID: 38227784)
21. Efficient radiosynthesis and preclinical evaluation of [
Singleton TA; Bdair H; Bailey JJ; Choi S; Aliaga A; Rosa-Neto P; Schirrmacher R; Bernard-Gauthier V; Kostikov A
J Labelled Comp Radiopharm; 2020 Mar; 63(3):144-150. PubMed ID: 31919878
[TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of PET radiotracers for imaging synaptic density, the acetylcholine transporter, AMPA-tarp-γ8 and muscarinic M4 receptors in Alzheimer's disease.
d'Orchymont F; Narvaez A; Raymond R; Sachdev P; Charil A; Krause S; Vasdev N
Am J Nucl Med Mol Imaging; 2024; 14(1):1-12. PubMed ID: 38500748
[TBL] [Abstract][Full Text] [Related]
23. TARP gamma-8 controls hippocampal AMPA receptor number, distribution and synaptic plasticity.
Rouach N; Byrd K; Petralia RS; Elias GM; Adesnik H; Tomita S; Karimzadegan S; Kealey C; Bredt DS; Nicoll RA
Nat Neurosci; 2005 Nov; 8(11):1525-33. PubMed ID: 16222232
[TBL] [Abstract][Full Text] [Related]
24. Assembly and stoichiometry of the AMPA receptor and transmembrane AMPA receptor regulatory protein complex.
Kim KS; Yan D; Tomita S
J Neurosci; 2010 Jan; 30(3):1064-72. PubMed ID: 20089915
[TBL] [Abstract][Full Text] [Related]
25. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
[TBL] [Abstract][Full Text] [Related]
26. Radiosynthesis and
Bdair H; Singleton TA; Ross K; Jolly D; Kang MS; Aliaga A; Tuznik M; Kaur T; Yous S; Soucy JP; Massarweh G; Scott PJH; Koeppe R; Spadoni G; Bedini A; Rudko DA; Gobbi G; Benkelfat C; Rosa-Neto P; Brooks AF; Kostikov A
ACS Chem Neurosci; 2022 May; 13(9):1382-1394. PubMed ID: 35420022
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of AMPA receptors (AMPARs) containing transmembrane AMPAR regulatory protein γ-8 with JNJ-55511118 shows preclinical efficacy in reducing chronic repetitive alcohol self-administration.
Hoffman JL; Faccidomo S; Saunders BL; Taylor SM; Kim M; Hodge CW
Alcohol Clin Exp Res; 2021 Jul; 45(7):1424-1435. PubMed ID: 34086361
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors.
Lodge NJ; Li YW; Chin FT; Dischino DD; Zoghbi SS; Deskus JA; Mattson RJ; Imaizumi M; Pieschl R; Molski TF; Fujita M; Dulac H; Zaczek R; Bronson JJ; Macor JE; Innis RB; Pike VW
Nucl Med Biol; 2014 Jul; 41(6):524-35. PubMed ID: 24793011
[TBL] [Abstract][Full Text] [Related]
29. TARP γ-7 selectively enhances synaptic expression of calcium-permeable AMPARs.
Studniarczyk D; Coombs I; Cull-Candy SG; Farrant M
Nat Neurosci; 2013 Sep; 16(9):1266-74. PubMed ID: 23872597
[TBL] [Abstract][Full Text] [Related]
30. Modulatory mechanisms of TARP γ8-selective AMPA receptor therapeutics.
Zhang D; Lape R; Shaikh SA; Kohegyi BK; Watson JF; Cais O; Nakagawa T; Greger IH
Nat Commun; 2023 Mar; 14(1):1659. PubMed ID: 36966141
[TBL] [Abstract][Full Text] [Related]
31. Novel
Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
[TBL] [Abstract][Full Text] [Related]
32. Characterizing the binding and function of TARP γ8-selective AMPA receptor modulators.
Dohrke JN; Watson JF; Birchall K; Greger IH
J Biol Chem; 2020 Oct; 295(43):14565-14577. PubMed ID: 32747446
[TBL] [Abstract][Full Text] [Related]
33. Molecular Mechanism of AMPA Receptor Modulation by TARP/Stargazin.
Ben-Yaacov A; Gillor M; Haham T; Parsai A; Qneibi M; Stern-Bach Y
Neuron; 2017 Mar; 93(5):1126-1137.e4. PubMed ID: 28238551
[TBL] [Abstract][Full Text] [Related]
34. 18F-FNDP for PET Imaging of Soluble Epoxide Hydrolase.
Horti AG; Wang Y; Minn I; Lan X; Wang J; Koehler RC; Alkayed NJ; Dannals RF; Pomper MG
J Nucl Med; 2016 Nov; 57(11):1817-1822. PubMed ID: 27417650
[TBL] [Abstract][Full Text] [Related]
35. Cornichon-2 modulates AMPA receptor-transmembrane AMPA receptor regulatory protein assembly to dictate gating and pharmacology.
Gill MB; Kato AS; Roberts MF; Yu H; Wang H; Tomita S; Bredt DS
J Neurosci; 2011 May; 31(18):6928-38. PubMed ID: 21543622
[TBL] [Abstract][Full Text] [Related]
36. TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating.
Milstein AD; Zhou W; Karimzadegan S; Bredt DS; Nicoll RA
Neuron; 2007 Sep; 55(6):905-18. PubMed ID: 17880894
[TBL] [Abstract][Full Text] [Related]
37.
Vidal B; Fieux S; Colom M; Billard T; Bouillot C; Barret O; Constantinescu C; Tamagnan G; Newman-Tancredi A; Zimmer L
Brain Struct Funct; 2018 Jul; 223(6):2973-2988. PubMed ID: 29730825
[TBL] [Abstract][Full Text] [Related]
38. A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [
Zheng C; Holden D; Zheng MQ; Pracitto R; Wilcox KC; Lindemann M; Felchner Z; Zhang L; Tong J; Fowles K; Finnema SJ; Nabulsi N; Carson RE; Huang Y; Cai Z
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1482-1496. PubMed ID: 34761284
[TBL] [Abstract][Full Text] [Related]
39. In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor.
Nebel N; Maschauer S; Kuwert T; Hocke C; Prante O
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589704
[TBL] [Abstract][Full Text] [Related]
40. Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611).
Witkin JM; Schober DA; Gleason SD; Catlow JT; Porter WJ; Reel J; Jin X; Hobbs J; Gehlert D; Gernert DL; Gardinier KM; Kato AS; Ping X; Smith JL
CNS Neurol Disord Drug Targets; 2017; 16(10):1099-1110. PubMed ID: 29090671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
